Kampala — Uganda is set to export medical marijuana products to Canada and Germany worth Shs600b in June, Daily Monitor has learnt.

It has also emerged that on December 7, 2017, Uganda exported unrefined cannabis buds/ flowers to South Africa’s National Analytical Forensic Services in Pretoria.

The order to Industrial Hemp (U) Ltd, a private company, was valued at $10,000 (Shs37.1m).

The marijuana exports from a farm in Kasese District include Cannabinol (CBD) and Tetrahydrocannabinol (THC) with mixture of 2.7mg THC and 2.5mg CBD for Sativex drugs approved in USA, Europe and Canada. Oil Risin contain Dronabinol for making Marinol and syndros capsules and CBD enriched creams for various skin disorders.

Mr Benjamin Cadet, one of the directors at Industrial Hemp (U) Ltd, a private firm jointly working with an Israel company, Together Pharma Ltd, yesterday confirmed medical cannabis orders from at least 20,000 pharmacies in Canada and Germany.

“We signed annual supply contracts with pharmacies in Canada to a tune of $100m and €58m for Germany… the current contracts run for 10 years but along the way, we shall expand to satisfy future demand,” Mr Cadet said.

“People are using morphine, the main component of opium as an analgesic for cancer pain. Opium is an Opioid and more addictive and with side effects yet Cannabinol (CBD) from medical marijuana is the best option for such patients… Cancer patients are using CBD illegally. We have the scientists and the technology to do this but regulations are not in place to allow cannabis drugs manufactured for domestic consumption,” he added.

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments